-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
What to Do When Two Households Become One
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
Jumia Reports Third Quarter 2026 Results
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
Devan Ekambaram and Susha’s 'Varuvaaiy' Makes History as First Tamil Song Nominated for a Grammy
-
Xreal Aura Review: A Comfortable VR Alternative With Flawed Controls
Healixa Turns Patents Into Products: FrostPulse(TM) Delivered and Five Eternal Spring(TM) Units Enter Production
Granted U.S. water harvesting patents, patent-pending FrostPulse™ cooling technology, first Northeast delivery and active water-system production mark Healixa's move into commercial execution
BOHEMIA, NY / ACCESS Newswire / November 18, 2026 / Healixa Inc. (OTCID:EMOR) ("Healixa" or the "Company") today announced that years of intellectual-property development and engineering work are producing tangible product and operating milestones across both of its core technology platforms.
The Company has received U.S. patents covering its Deposition Water Harvesting™ technology, filed patent applications covering FrostPulse™ cooling technology, delivered its first FrostPulse™-branded cooling device in the Northeast and placed five Eternal Spring™ water-harvesting units into production.
These milestones follow Healixa's introduction of FrostPulse™ as a response to the growing water and energy demands of data center cooling. They also demonstrate that Healixa's broader strategy at the intersection of water and energy is advancing beyond technology development and into physical products, field activity and manufacturing.
"For years, the market could only see pieces of what we were building. That changes now," said Bret Hedges, President of Healixa and Chief Executive Officer of Healixa IQ. "We have protected our water technology, filed patent applications around FrostPulse™, delivered the first FrostPulse™-branded device and moved five Eternal Spring™ units into production. This is how we intend to build credibility: milestone by milestone, product by product."
U.S. Patent Protection for Eternal Spring™
Healixa's granted U.S. patents protect core elements of the Company's Deposition Water Harvesting™ technology, which forms the foundation of the Eternal Spring™ platform. Eternal Spring™ is designed to create fresh water directly from atmospheric moisture for applications where conventional water supplies are scarce, costly or unreliable.
The granted patents strengthen Healixa's intellectual-property foundation as the Company advances production and develops commercial channels for its water technology. Healixa has also filed additional patent applications as it continues to advance the platform.
FrostPulse™ Patent Applications Filed
Healixa has filed patent applications covering its FrostPulse™ cooling technology, and those applications are patent pending. FrostPulse™ is the Company's next-generation primary cooling platform for data centers, medical imaging, industrial processes, telecommunications and commercial infrastructure.
The FrostPulse™ architecture is designed to respond to rapidly changing thermal demand while reducing dependence on conventional cooling towers and condenser-water infrastructure. Healixa believes this approach can help operators address the growing water and energy burden associated with modern high-density compute and other demanding applications.
First FrostPulse™-Branded Device Delivered
Healixa has delivered its first FrostPulse™-branded cooling device to a location in the Northeast. The delivery advances FrostPulse™ from the Company's engineering and development program toward a planned field deployment.
Healixa intends to announce the deployment location, application and additional project details separately.
Five Eternal Spring™ Units in Production
Five Eternal Spring™ water-harvesting units are now in production. The systems represent an important step in Healixa's manufacturing buildout and planned commercial rollout for its patented water platform.
Production of the five units will allow Healixa to refine manufacturing procedures, strengthen its supply chain and prepare the Eternal Spring™ platform for broader distribution and deployment.
"Patents protect the foundation, but delivery and production show what that foundation can become," said Ian Parker, Chief Executive Officer of Healixa. "FrostPulse™ and Eternal Spring™ were built to address two of the hardest infrastructure problems in front of us: how we cool the next generation of compute and how we create reliable access to water. Both technologies are now advancing from intellectual-property development and engineering into physical products and field activity."
Healixa expects to provide additional updates regarding the first FrostPulse™ field deployment, its rebuilt commercial websites, distribution channels, Eternal Spring™ production progress, and connected monitoring and fleet-management capabilities.
About Healixa Inc.
Healixa Inc. (OTC: EMOR) is a thermal innovation company developing and commercializing technologies for water security and infrastructure cooling. FrostPulse™ is Healixa's next-generation primary cooling platform for data centers, medical imaging, industrial processes, telecommunications and commercial infrastructure. The Company's Eternal Spring™ platform applies its patented Deposition Water Harvesting™ technology to produce fresh water from atmospheric moisture.
For more information, visit www.healixa.com.
Forward-Looking Statements
Certain statements contained in this press release may constitute forward-looking statements within the meaning of applicable securities laws. These statements include, among others, statements concerning commercialization, manufacturing, production, future deployments, distribution, product performance, market opportunities, intellectual property and future company announcements.
Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, but are not limited to, the Company's ability to obtain financing, complete manufacturing, manage supply chains, protect its intellectual property, achieve expected product performance, secure customers and distribution partners, and satisfy applicable regulatory and operational requirements. Healixa undertakes no obligation to update any forward-looking statement except as required by law.
Investor Relations
Healixa Inc.
273 Knickerbocker Ave.
Bohemia, NY 11716
(833) 432-5492
[email protected]
www.healixa.com
SOURCE: Healixa Inc.
View the original press release on ACCESS Newswire
O.M.Souza--AMWN